| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 23, 2026 4:00 P.M. |
| Form: | S-4 | ||||||
| |||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 23, 2026 4:00 P.M. |
| Form: | S-4 | ||||||
| |||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)
8-K - Churchill Capital Corp X/Cayman (0002007825) (Filer)
425 - Churchill Capital Corp X/Cayman (0002007825) (Subject)
Backed by Wellcome Leap program funding and selected to advance to final-stage demonstrations, Infleqtion moves forward with quantum-enabled biomarker discovery for precision oncology Infleqtion, a global leader in quantum sensing and quantum computing powered by neutral-atom technology, announced that its quantum software team, together with collaborators at the University of Chicago (UChicago) and Massachusetts Institute of Technology (MIT), has been selected to advance to Phase 3 of the Wellcome Leap Quantum for Bio (Q4Bio) Challenge, a global program focused on demonstrating quantum-enabled solutions for human health. The news comes as Infleqtion prepares to go public through a merger
Combined Company to Trade on NYSE as "INFQ" Churchill Capital Corp X ("Churchill X"), a special purpose acquisition company, today announced Churchill X's intent to transfer the listing of its Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares") and public warrants (the "CCX Warrants") (each, the Common Stock and Warrants following transactions contemplated by the Business Combination, as defined below), from the Nasdaq Stock Market LLC ("Nasdaq") to the New York Stock Exchange (the "NYSE") following, and subject to the completion of, its previously announced business combination with ColdQuanta, Inc. (d/b/a Infleqtion) ("Infleqtion", and such related trans
New research allows for faster computation cycles and more robust error correction, accelerating Infleqtion's path toward industrial-scale neutral-atom quantum computers Infleqtion, a global leader in quantum sensing and quantum computing, announced research results from a collaboration with the University of Wisconsin–Madison that demonstrate a more reliable way to measure individual quantum bits, or qubits, without interrupting ongoing circuits. The work addresses one of the central challenges in quantum computing by enabling faster computation cycles while preserving fragile quantum states. This announcement follows Infleqtion's plans to go public through a merger with Churchill Capita
3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)
3 - Churchill Capital Corp X/Cayman (0002007825) (Issuer)